Magle Chemoswed Holding AB

OSTO:MAGLE (Sweden)   Ordinary Shares
kr 33.80 (0%) Jun 3
29.91
P/B:
2.26
Market Cap:
kr 365.04M ($ 35.06M)
Enterprise V:
kr 430.92M ($ 41.38M)
Volume:
130.00
Avg Vol (2M):
939.00
Also Trade In:
Volume:
130.00
Avg Vol (2M):
939.00
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Magle Chemoswed Holding AB ( OSTO:MAGLE ) from 2020 to Jun 04 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Magle Chemoswed Holding AB stock (OSTO:MAGLE) PE ratio as of Jun 04 2024 is 29.91. More Details

Magle Chemoswed Holding AB (OSTO:MAGLE) PE Ratio (TTM) Chart

To

Magle Chemoswed Holding AB (OSTO:MAGLE) PE Ratio (TTM) Historical Data

Total 1019
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 12
Magle Chemoswed Holding AB PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-04 29.9 2024-04-02 28.7
2024-06-03 29.9 2024-04-01 28.5
2024-05-31 29.9 2024-03-29 28.5
2024-05-30 28.7 2024-03-28 28.5
2024-05-29 28.7 2024-03-27 27.6
2024-05-28 29.6 2024-03-26 26.6
2024-05-27 29.4 2024-03-25 26.4
2024-05-24 29.6 2024-03-22 25.8
2024-05-23 29.4 2024-03-21 25.5
2024-05-22 29.7 2024-03-20 24.8
2024-05-21 29.4 2024-03-19 24.8
2024-05-20 29.4 2024-03-18 24.8
2024-05-17 28.5 2024-03-15 24.8
2024-05-16 28.7 2024-03-14 25.0
2024-05-15 28.7 2024-03-13 24.6
2024-05-14 28.7 2024-03-12 24.1
2024-05-13 28.7 2024-03-11 23.9
2024-05-10 28.3 2024-03-08 22.5
2024-05-09 28.3 2024-03-07 22.6
2024-05-08 28.3 2024-03-06 21.6
2024-05-07 28.3 2024-03-05 22.3
2024-05-06 28.3 2024-03-04 22.3
2024-05-03 28.3 2024-03-01 22.6
2024-05-02 26.7 2024-02-29 22.3
2024-05-01 26.7 2024-02-28 22.3
2024-04-30 26.7 2024-02-27 22.3
2024-04-29 26.6 2024-02-26 22.8
2024-04-26 26.6 2024-02-23 23.4
2024-04-25 26.7 2024-02-22 22.8
2024-04-24 26.7 2024-02-21 22.8
2024-04-23 27.8 2024-02-20 23.9
2024-04-22 27.4 2024-02-19 24.4
2024-04-19 27.4 2024-02-16 24.8
2024-04-18 26.7 2024-02-15 22.3
2024-04-17 28.9 2024-02-14 22.3
2024-04-16 28.9 2024-02-13 22.3
2024-04-15 29.7 2024-02-12 22.1
2024-04-12 29.4 2024-02-09 22.1
2024-04-11 30.1 2024-02-08 22.1
2024-04-10 29.9 2024-02-07 22.1
2024-04-09 29.2 2024-02-06 22.1
2024-04-08 29.9 2024-02-05 22.1
2024-04-05 29.7 2024-02-02 22.8
2024-04-04 29.4 2024-02-01 22.8
2024-04-03 29.6 2024-01-31 22.8

Magle Chemoswed Holding AB (OSTO:MAGLE) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.